Quality-related events reported by community pharmacies in Nova Scotia over a 7-year period: a descriptive analysis
| Autor: | James R. Barker, Andrea Bishop, Certina Ho, Todd A. Boyle, Neil J. MacKinnon, Adrian Boucher, Christopher M. Hartt, Paola A. Gonzalez |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Nova scotia
Community pharmacies medicine.medical_specialty Quality management Descriptive statistics business.industry media_common.quotation_subject Research MEDLINE General Medicine Near miss 030226 pharmacology & pharmacy Order entry 03 medical and health sciences 0302 clinical medicine Family medicine medicine Quality (business) 030212 general & internal medicine business media_common |
| Zdroj: | CMAJ open. 6(4) |
| ISSN: | 2291-0026 |
| Popis: | Background Quality-related events are defined as medication errors that reach the patient (e.g., incorrect drug, dose and quantity), in addition to medication errors that are intercepted before dispensing (i.e., near misses). The aim of this study is to quantify and characterize such events as reported by community pharmacies in a Canadian province. Methods A retrospective analysis was conducted on quality-related events reported to the Community Pharmacy Incident Reporting system from 301 community pharmacies in Nova Scotia between Oct. 1, 2010, and June 30, 2017. We performed a descriptive analysis on these events with respect to the discoverer, patient outcome, medication system stages and type. Results We identified 131 031 events reported by community pharmacies in Nova Scotia over the study period, 98 097 of which were quality-related events. Overall, 82.0% (n = 80 488) quality-related events did not reach the patient, and 0.95% (n = 928) were associated with patient harm. Incorrect dose or frequency, incorrect quantity and incorrect drug were the most common types of quality-related events reported. Most of the quality-related events occurred at order entry, followed by preparation and dispensing, and prescribing. Interpretation Quality-related events reported by community pharmacies differ from those reported in institutional settings with respect to patient outcome, medication system stages and type. This analysis provides valuable information to guide quality improvement initiatives to strengthen medication safety in community pharmacies. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|